Aerosol-based efficient delivery of azithromycin to alveolar macrophages for treatment of respiratory infections

References

• Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545–1555.
   PubMed Web of Science ®Google Scholar
• Waterer G, Wunderink R. Respiratory infections: a current and future threat. Respirology 2009;14:651–655.
   PubMed Web of Science ®Google Scholar
• Wong SS, Yuen KY. Antiviral therapy for respiratory tract infections. Respirology 2008;13:950–971.
   PubMedGoogle Scholar
• Ferrari G, Langen H, Naito M, Pieters J. A coat protein on phagosomes involved in the intracellular survival of mycobacteria. Cell 1999;97:435–447.
   PubMed Web of Science ®Google Scholar
• Greub G, Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 2004;17:413–433.
   PubMed Web of Science ®Google Scholar
• Harb OS, Gao LY, Abu Kwaik Y. From protozoa to mammalian cells: a new paradigm in the life cycle of intracellular bacterial pathogens. Environ Microbiol 2000;2:251–265.
   PubMed Web of Science ®Google Scholar
• Doganay M. Listeriosis: clinical presentation. FEMS Immunol Med Microbiol 2003;35:173–175.
   PubMed Web of Science ®Google Scholar
• Ellner JJ, Goldberger MJ, Parenti DM. Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J Infect Dis 1991;163:1326–1335.
   PubMed Web of Science ®Google Scholar
• Frieden TR, Sterling TR, Munsiff SS, Watt CJ, Dye C. Tuberculosis. Lancet 2003;362:887–899.
   PubMed Web of Science ®Google Scholar
• Nara C, Tateda K, Matsumoto T, Ohara A, Miyazaki S, Standiford TJ et al. Legionella-induced acute lung injury in the setting of hyperoxia: protective role of tumour necrosis factor-alpha. J Med Microbiol 2004;53:727–733.
   PubMed Web of Science ®Google Scholar
• Tärnvik A, Berglund L. Tularaemia. Eur Respir J 2003;21:361–373.
   PubMed Web of Science ®Google Scholar
• Tsai MH, Huang YC, Chen CJ, Lin PY, Chang LY, Chiu CH et al. Chlamydial pneumonia in children requiring hospitalization: effect of mixed infection on clinical outcome. J Microbiol Immunol Infect 2005;38:117–122.
   PubMedGoogle Scholar
• Roig J, Casal J, Gispert P, Gea E. 13–Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents. Med Mal Infect 2006;36:680–689.
   PubMedGoogle Scholar
• Vergis EN, Indorf A, File TM Jr, Phillips J, Bates J, Tan J et al. Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. Arch Intern Med 2000;160:1294–1300.
   PubMedGoogle Scholar
• Foulds G, Shepard RM, Johnson RB. The pharmacokinetics of azithromycin in human serum and tissues. J Antimicrob Chemother 1990;25 Suppl A:73–82.
   PubMed Web of Science ®Google Scholar
• Longo G, Valenti C, Gandini G, Ferrara L, Bertesi M, Emilia G. Azithromycin-induced intrahepatic cholestasis. Am J Med 1997;102:217–218.
   PubMed Web of Science ®Google Scholar
• Antonini JM, Reasor MJ. Accumulation of amiodarone and desethylamiodarone by rat alveolar macrophages in cell culture. Biochem Pharmacol 1991;42 Suppl:S151–S156.
   Google Scholar
• Kohno Y, Yoshida H, Suwa T, Suga T. Uptake of clarithromycin by rat lung cells. J Antimicrob Chemother 1990;26:503–513.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Hunt C, Macgregor R, Siegel R. Engineering Targeted In Vivo Drug Delivery. I. The Physiological and Physicochemical Principles Governing Opportunities and Limitations. Pharm Res 1986;3:333–334.
   PubMed Web of Science ®Google Scholar
• Muto C, Liu P, Chiba K, Suwa T. Pharmacokinetic-pharmacodynamic analysis of azithromycin extended release in Japanese patients with common respiratory tract infectious disease. J Antimicrob Chemother 2011;66:165–174.
   PubMedGoogle Scholar
• Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: methodological considerations. Antimicrob Agents Chemother 1992;36:1171–1175.
   PubMed Web of Science ®Google Scholar
• Wang F, Daugherty B, Keise LL, Wei Z, Foley JP, Savani RC et al. Heterogeneity of claudin expression by alveolar epithelial cells. Am J Respir Cell Mol Biol 2003;29:62–70.
   PubMed Web of Science ®Google Scholar
• Campbell L, Abulrob AN, Kandalaft LE, Plummer S, Hollins AJ, Gibbs A et al. Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures. J Pharmacol Exp Ther 2003;304:441–452.
   PubMed Web of Science ®Google Scholar
• Zaman GJ, Versantvoort CH, Smit JJ, Eijdems EW, de Haas M, Smith AJ et al. Analysis of the expression of MRP, the gene for a new putative transmembrane drug transporter, in human multidrug resistant lung cancer cell lines. Cancer Res 1993;53:1747–1750.
   PubMed Web of Science ®Google Scholar
• Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265–269.
   PubMed Web of Science ®Google Scholar
• Togami K, Chono S, Morimoto K. Distribution characteristics of clarithromycin and azithromycin, macrolide antimicrobial agents used for treatment of respiratory infections, in lung epithelial lining fluid and alveolar macrophages. Biopharm Drug Dispos 2011;32:389–397.
   PubMed Web of Science ®Google Scholar
• Vazifeh D, Abdelghaffar H, Labro MT. Effect of telithromycin (HMR 3647) on polymorphonuclear neutrophil killing of Staphylococcus aureus in comparison with roxithromycin. Antimicrob Agents Chemother 2002;46:1364–1374.
   PubMed Web of Science ®Google Scholar
• Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs. Int J Antimicrob Agents 2002;19:355–358.
   PubMed Web of Science ®Google Scholar
• Mouton JW, Dudley MN, Cars O, Derendorf H, Drusano GL. Standardization of pharmacokinetic/pharmacodynamic (PK/PD) terminology for anti-infective drugs: an update. J Antimicrob Chemother 2005;55:601–607.
   PubMed Web of Science ®Google Scholar
• Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae. J Antimicrob Chemother 2003;52:497–499.
   PubMed Web of Science ®Google Scholar
• Dubois J, St-Pierre C. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp. J Antimicrob Chemother 2000;45 Suppl 1:41–46.
   PubMedGoogle Scholar
• Krishnan MY, Manning EJ, Collins MT. Comparison of three methods for susceptibility testing of Mycobacterium avium subsp. paratuberculosis to 11 antimicrobial drugs. J Antimicrob Chemother 2009;64:310–316.
   PubMed Web of Science ®Google Scholar